ro-13-6298 and Body-Weight

ro-13-6298 has been researched along with Body-Weight* in 1 studies

Other Studies

1 other study(ies) available for ro-13-6298 and Body-Weight

Article	Year
The effects of arotinoids on rat mammary carcinogenesis. Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:2 The influence of two retinoids, Ro 13-6298, an arotinoid ethyl ester, and Ro 15-1570, an arotinoid ethyl sulfone, on rat mammary carcinogenesis was investigated. Mammary carcinomas were induced by oral administration of 15 mg dimethylbenz(a)anthracene (DMBA) to 50-day-old female Sprague-Dawley rats. Oral administration of the two retinoids significantly inhibited the development of tumors. The number and volume of mammary neoplasms were influenced in a dose-dependent manner. Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoates; Body Weight; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Retinoids	1985

Article

Year

The effects of arotinoids on rat mammary carcinogenesis.

Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:2

The influence of two retinoids, Ro 13-6298, an arotinoid ethyl ester, and Ro 15-1570, an arotinoid ethyl sulfone, on rat mammary carcinogenesis was investigated. Mammary carcinomas were induced by oral administration of 15 mg dimethylbenz(a)anthracene (DMBA) to 50-day-old female Sprague-Dawley rats. Oral administration of the two retinoids significantly inhibited the development of tumors. The number and volume of mammary neoplasms were influenced in a dose-dependent manner.

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoates; Body Weight; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Retinoids

1985